Mutations provided the fact that, as described underneath, CLL therapy is predicated over the presence or absence of such mutations. The existing consensus is always that, apart from clonal mutations, subclonal mutations that has a variant allelic frequency starting from 5 to 10% (and so below the edge of detection https://barbaraf086wfn3.wikirecognition.com/user